Astrana Health, Inc. (NASDAQ:ASTH) Given Consensus Rating of “Moderate Buy” by Brokerages

Astrana Health, Inc. (NASDAQ:ASTH) has received a consensus recommendation of “Moderate Buy” from the ten analysts that are covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have given a buy rating to the company. The average 1-year target price among analysts that have issued a report on the stock in the last year is $53.2857.

Separately, Zacks Research lowered Astrana Health from a “strong-buy” rating to a “strong sell” rating in a research note on Monday, September 1st.

Institutional Investors Weigh In On Astrana Health

Hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. grew its position in Astrana Health by 4.5% during the 1st quarter. Vanguard Group Inc. now owns 4,898,992 shares of the company’s stock worth $151,918,000 after acquiring an additional 213,033 shares during the last quarter. Hotchkis & Wiley Capital Management LLC bought a new position in Astrana Health in the 1st quarter valued at $5,564,000. Jacobs Levy Equity Management Inc. boosted its stake in Astrana Health by 211.6% in the first quarter. Jacobs Levy Equity Management Inc. now owns 237,926 shares of the company’s stock worth $7,378,000 after purchasing an additional 161,580 shares in the last quarter. AXA S.A. bought a new stake in shares of Astrana Health during the second quarter worth $3,150,000. Finally, Nuveen LLC bought a new stake in shares of Astrana Health during the first quarter worth $3,369,000. Institutional investors and hedge funds own 52.77% of the company’s stock.

Astrana Health Stock Performance

NASDAQ:ASTH opened at $30.26 on Wednesday. The firm has a market capitalization of $1.70 billion, a PE ratio of 59.33, a price-to-earnings-growth ratio of 0.73 and a beta of 0.85. The company has a quick ratio of 1.59, a current ratio of 1.59 and a debt-to-equity ratio of 0.52. Astrana Health has a 12-month low of $21.20 and a 12-month high of $63.20. The firm has a 50-day moving average price of $26.68 and a 200 day moving average price of $28.04.

Astrana Health (NASDAQ:ASTH) last released its quarterly earnings data on Thursday, August 7th. The company reported $0.19 earnings per share for the quarter, missing analysts’ consensus estimates of $0.36 by ($0.17). Astrana Health had a net margin of 1.04% and a return on equity of 3.43%. The company had revenue of $654.81 million for the quarter, compared to analyst estimates of $639.13 million. During the same period in the previous year, the firm posted $0.40 earnings per share. The firm’s revenue for the quarter was up 34.7% compared to the same quarter last year. Astrana Health has set its Q3 2025 guidance at EPS. Research analysts anticipate that Astrana Health will post 1.15 earnings per share for the current fiscal year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.